Keywords: update, sanofi-aventis, reports, forecast-beating, earnings, 1st-qtr, sales
UPDATE: Sanofi-Aventis reports forecast-beating earnings, 1st-qtr sales up 11.9%
Article | 23 May 2005
Coming in line with most drug analysts' expectations, France's Sanofi-Aventis, the world's third-largest drugmaker, has posted strong first-quarter 2005 results with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
